CN1514735A - 含有透明质酸的眼药组合物 - Google Patents
含有透明质酸的眼药组合物 Download PDFInfo
- Publication number
- CN1514735A CN1514735A CNA028115317A CN02811531A CN1514735A CN 1514735 A CN1514735 A CN 1514735A CN A028115317 A CNA028115317 A CN A028115317A CN 02811531 A CN02811531 A CN 02811531A CN 1514735 A CN1514735 A CN 1514735A
- Authority
- CN
- China
- Prior art keywords
- described compositions
- compositions
- treatment
- ketotifen
- eyes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01113959 | 2001-06-08 | ||
EP01113958 | 2001-06-08 | ||
EP01113959.9 | 2001-06-08 | ||
EP01113958.1 | 2001-06-08 | ||
EP01115097 | 2001-06-21 | ||
EP01115096 | 2001-06-21 | ||
EP01115096.8 | 2001-06-21 | ||
EP01115097.6 | 2001-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1514735A true CN1514735A (zh) | 2004-07-21 |
Family
ID=27440131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA028115317A Pending CN1514735A (zh) | 2001-06-08 | 2002-06-07 | 含有透明质酸的眼药组合物 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1404370A2 (fr) |
JP (1) | JP2005508866A (fr) |
CN (1) | CN1514735A (fr) |
AR (1) | AR034371A1 (fr) |
AU (1) | AU2002314149A1 (fr) |
BR (1) | BR0210139A (fr) |
CA (1) | CA2449213A1 (fr) |
PE (1) | PE20030206A1 (fr) |
WO (1) | WO2002100437A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100408046C (zh) * | 2005-12-22 | 2008-08-06 | 涂家生 | 大环内酯类抗生素玻璃酸钠眼用传输系统 |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002100436A2 (fr) * | 2001-06-08 | 2002-12-19 | Novartis Ag | Compositions pharmaceutiques |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
JP2004143155A (ja) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
US20040137079A1 (en) * | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
JP5222462B2 (ja) * | 2003-08-21 | 2013-06-26 | スキャンポ・アーゲー | 眼科用組成物 |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
US20050101582A1 (en) * | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
JP2007518804A (ja) * | 2004-01-20 | 2007-07-12 | アラーガン、インコーポレイテッド | トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物 |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
DE102005035986B4 (de) * | 2005-07-28 | 2009-10-15 | Bausch & Lomb Incorporated | Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat |
US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
WO2012047893A2 (fr) * | 2010-10-04 | 2012-04-12 | Activbiotics Pharma, Llc | Utilisation de rifalazil et d'analogues de celui-ci pour le traitement de troubles oculaires |
KR101412776B1 (ko) | 2013-03-11 | 2014-07-01 | 가톨릭대학교 산학협력단 | 각결막염 치료용 점안제 조성물 및 이의 제조 방법 |
US10064818B2 (en) | 2013-08-28 | 2018-09-04 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
US9968594B2 (en) | 2013-08-28 | 2018-05-15 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
US9314427B2 (en) | 2013-08-28 | 2016-04-19 | Presbyopia Therapies Llc | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye |
US9320709B2 (en) | 2013-08-28 | 2016-04-26 | Presbyopia Therapies Llc | Storage stable compositions and methods for the treatment of refractive errors of the eye |
US9844537B2 (en) | 2013-08-28 | 2017-12-19 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
US11179327B2 (en) | 2013-08-28 | 2021-11-23 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
US10307408B2 (en) | 2013-08-28 | 2019-06-04 | Presbyopia Therapies, LLC | Contact lens compositions and methods for the treatment of presbyopia |
US9089562B2 (en) | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
US10617763B2 (en) | 2013-08-28 | 2020-04-14 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
US9833441B2 (en) | 2013-08-28 | 2017-12-05 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
CA3031370A1 (fr) | 2016-08-19 | 2018-02-22 | Orasis Pharmaceuticals Ltd. | Compositions pharmaceutiques ophtalmiques et utilisations associees |
US11648247B1 (en) | 2021-12-16 | 2023-05-16 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
RU2089191C1 (ru) * | 1994-01-28 | 1997-09-10 | Научно-производственная фирма "Нарт" | Способ пролонгирования физиологического эффекта тимолола снижать внутриглазное давление |
CA2193149C (fr) * | 1995-12-22 | 2002-04-23 | David H. Donabedian | Systemes cationiques therapeutiques |
JPH1160505A (ja) * | 1997-05-20 | 1999-03-02 | Senju Pharmaceut Co Ltd | 防腐組成物 |
DE19923829A1 (de) * | 1999-05-17 | 2000-11-23 | Ulrich Kluegel | Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung |
US6777429B1 (en) * | 1999-07-23 | 2004-08-17 | Novartis Ag | Ophthalmic composition |
-
2002
- 2002-06-06 AR ARP020102106A patent/AR034371A1/es unknown
- 2002-06-07 EP EP02740697A patent/EP1404370A2/fr not_active Withdrawn
- 2002-06-07 JP JP2003503256A patent/JP2005508866A/ja active Pending
- 2002-06-07 WO PCT/EP2002/006279 patent/WO2002100437A2/fr not_active Application Discontinuation
- 2002-06-07 CN CNA028115317A patent/CN1514735A/zh active Pending
- 2002-06-07 PE PE2002000483A patent/PE20030206A1/es not_active Application Discontinuation
- 2002-06-07 BR BR0210139-4A patent/BR0210139A/pt not_active Application Discontinuation
- 2002-06-07 AU AU2002314149A patent/AU2002314149A1/en not_active Abandoned
- 2002-06-07 CA CA002449213A patent/CA2449213A1/fr not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100408046C (zh) * | 2005-12-22 | 2008-08-06 | 涂家生 | 大环内酯类抗生素玻璃酸钠眼用传输系统 |
Also Published As
Publication number | Publication date |
---|---|
JP2005508866A (ja) | 2005-04-07 |
BR0210139A (pt) | 2004-06-08 |
CA2449213A1 (fr) | 2002-12-19 |
AU2002314149A1 (en) | 2002-12-23 |
WO2002100437A3 (fr) | 2003-04-24 |
EP1404370A2 (fr) | 2004-04-07 |
AR034371A1 (es) | 2004-02-18 |
PE20030206A1 (es) | 2003-04-09 |
WO2002100437A2 (fr) | 2002-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1514735A (zh) | 含有透明质酸的眼药组合物 | |
RU2330668C2 (ru) | Применение римексолона для лечения синдрома сухого глаза | |
JP7088980B2 (ja) | セチリジンの眼科用製剤および使用方法 | |
US20100240624A1 (en) | Ophthalmic Formulations of Ketotifen and Methods of Use | |
KR101541303B1 (ko) | 보레이트-폴리올 복합체를 함유하는 수성 약학적 조성물 | |
CN100366251C (zh) | 包含子囊霉素的眼用组合物 | |
US20120093876A1 (en) | Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions | |
ES2543349T5 (es) | Composiciones farmacéuticas acuosas autoconservadas | |
JPWO2016190306A1 (ja) | 水性眼科組成物 | |
CN1092954C (zh) | 含环糊精和季铵化合物的眼用组合物 | |
JP5275214B2 (ja) | 酸化に不安定な成分を含む眼科用安定組成物 | |
EP3653205A2 (fr) | Oxymethazoline pour administration topique oculaire et ses utilisations | |
US20050239745A1 (en) | Novel topical ophthalmic formulations | |
WO2009061431A2 (fr) | Compositions pour le traitement et la prévention du gonflement des paupières | |
WO2011116020A2 (fr) | Formulations ophthalmiques de cétirizine et leurs méthodes d'utilisation | |
KR102663319B1 (ko) | 안구 장애를 치료하기 위한 옥시메타졸린 조성물 및 방법 | |
Missel et al. | Design and evaluation of ophthalmic pharmaceutical products | |
CN104602685A (zh) | 用于预防和/或治疗干眼症的的组合物、方法和/或装置 | |
WO2002100376A1 (fr) | Compositions ophtalmiques comprenant du chitosan et une substance active, en particulier du ketotifen, et utilisations de ces dernieres dans le traitement d'etats d'allergie oculaire | |
KR20130092957A (ko) | 안과용 처방용 보존제 조성물의 조합 | |
JP5499535B2 (ja) | 眼科用組成物及びなみだ目改善剤 | |
JP2007297331A (ja) | パントテン酸類含有水性組成物 | |
JPH11147825A (ja) | 粘膜吸収性の向上方法及び粘膜外用剤 | |
WO2002100436A2 (fr) | Compositions pharmaceutiques | |
CN1483478A (zh) | 一种适用于治疗性药物的眼制剂组方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |